This is the authors' abstract. We don't add key points for this paper.
Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β-cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this article are protocols for producing STZ-induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Brian L. Furman (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: